162 related articles for article (PubMed ID: 18791937)
21. Novel point mutations in the alphaIIb subunit (Phe289-->Ser, Glu324-->Lys and Gln747-->Pro) causing thrombasthenic phenotypes in four Japanese patients.
Ambo H; Kamata T; Handa M; Kawai Y; Oda A; Murata M; Takada Y; Ikeda Y
Br J Haematol; 1998 Aug; 102(3):829-40. PubMed ID: 9722314
[TBL] [Abstract][Full Text] [Related]
22. A Leu117-->Trp mutation within the RGD-peptide cross-linking region of beta3 results in Glanzmann thrombasthenia by preventing alphaIIb beta3 export to the platelet surface.
Basani RB; Brown DL; Vilaire G; Bennett JS; Poncz M
Blood; 1997 Oct; 90(8):3082-8. PubMed ID: 9376589
[TBL] [Abstract][Full Text] [Related]
23. Glanzmann thrombasthenia: integrin alpha IIb beta 3 deficiency.
Tomiyama Y
Int J Hematol; 2000 Dec; 72(4):448-54. PubMed ID: 11197210
[TBL] [Abstract][Full Text] [Related]
24. Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway.
Pasquet JM; Noury M; Nurden AT
Thromb Haemost; 2002 Jul; 88(1):115-22. PubMed ID: 12152651
[TBL] [Abstract][Full Text] [Related]
25. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
Grimaldi CM; Chen F; Wu C; Weiss HJ; Coller BS; French DL
Blood; 1998 Mar; 91(5):1562-71. PubMed ID: 9473221
[TBL] [Abstract][Full Text] [Related]
26. Distinct domains of alphaIIbbeta3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIbbeta3 interacting peptide.
Derrick JM; Shattil SJ; Poncz M; Gruppo RA; Gartner TK
Thromb Haemost; 2001 Sep; 86(3):894-901. PubMed ID: 11583324
[TBL] [Abstract][Full Text] [Related]
27. A three amino acid deletion in glycoprotein IIIa is responsible for type I Glanzmann's thrombasthenia: importance of residues Ile325Pro326Gly327 for beta3 integrin subunit association.
Morel-Kopp MC; Kaplan C; Proulle V; Jallu V; Melchior C; Peyruchaud O; Aurousseau MH; Kieffer N
Blood; 1997 Jul; 90(2):669-77. PubMed ID: 9226167
[TBL] [Abstract][Full Text] [Related]
28. A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen.
Ward CM; Kestin AS; Newman PJ
Blood; 2000 Jul; 96(1):161-9. PubMed ID: 10891446
[TBL] [Abstract][Full Text] [Related]
29. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
Kiyoi T; Tomiyama Y; Honda S; Tadokoro S; Arai M; Kashiwagi H; Kosugi S; Kato H; Kurata Y; Matsuzawa Y
Blood; 2003 May; 101(9):3485-91. PubMed ID: 12506038
[TBL] [Abstract][Full Text] [Related]
30. A Ser752-->Pro substitution in the cytoplasmic domain of beta3 in a Glanzmann thrombasthenia variant fails to prevent interactions between the alphaIIbbeta3 integrin and the platelet granule pool of fibrinogen.
Nurden P; Poujol C; Winckler J; Combrié R; Caen JP; Nurden AT
Br J Haematol; 2002 Sep; 118(4):1143-51. PubMed ID: 12199799
[TBL] [Abstract][Full Text] [Related]
31. Analysis of platelet membrane glycoprotein polymorphisms in Glanzmann thrombasthenia showed the French gypsy mutation in the alphaIIb gene to be strongly linked to the HPA-1b polymorphism in beta3.
Jacquelin B; Tuleja E; Kunicki TJ; Nurden P; Nurden AT
J Thromb Haemost; 2003 Mar; 1(3):573-5. PubMed ID: 12871468
[TBL] [Abstract][Full Text] [Related]
32. A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins.
McDowall A; Inwald D; Leitinger B; Jones A; Liesner R; Klein N; Hogg N
J Clin Invest; 2003 Jan; 111(1):51-60. PubMed ID: 12511588
[TBL] [Abstract][Full Text] [Related]
33. A mutant (Arg327-->His) GPIIb associated to thrombasthenia exerts a dominant negative effect in stably transfected CHO cells.
Ferrer M; Fernández-Pinel M; González-Manchón C; González J; Ayuso MS; Parrilla R
Thromb Haemost; 1996 Sep; 76(3):292-301. PubMed ID: 8883261
[TBL] [Abstract][Full Text] [Related]
34. A mutation in the integrin alphaIIb subunit that selectively inhibits alphaIIb beta3 receptor function.
Perkins KB; Loftus JC
Thromb Haemost; 2003 Nov; 90(5):853-62. PubMed ID: 14597981
[TBL] [Abstract][Full Text] [Related]
35. A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro.
Baker EK; Tozer EC; Pfaff M; Shattil SJ; Loftus JC; Ginsberg MH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1973-8. PubMed ID: 9050889
[TBL] [Abstract][Full Text] [Related]
36. Three novel integrin beta3 subunit missense mutations (H280P, C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients.
Ambo H; Kamata T; Handa M; Taki M; Kuwajima M; Kawai Y; Oda A; Murata M; Takada Y; Watanabe K; Ikeda Y
Biochem Biophys Res Commun; 1998 Oct; 251(3):763-8. PubMed ID: 9790984
[TBL] [Abstract][Full Text] [Related]
37. Structure and function of murine alphaIIbbeta3 (GPIIb/IIIa): studies using monoclonal antibodies and beta3-null mice,
Smyth SS; Tsakiris DA; Scudder LE; Coller BS
Thromb Haemost; 2000 Dec; 84(6):1103-8. PubMed ID: 11154120
[TBL] [Abstract][Full Text] [Related]
38. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.
Wang R; Shattil SJ; Ambruso DR; Newman PJ
J Clin Invest; 1997 Nov; 100(9):2393-403. PubMed ID: 9351872
[TBL] [Abstract][Full Text] [Related]
39. Two genetic defects in alphaIIb are associated with type I Glanzmann's thrombasthenia in a Great Pyrenees dog: a 14-base insertion in exon 13 and a splicing defect of intron 13.
Lipscomb DL; Bourne C; Boudreaux MK
Vet Pathol; 2000 Nov; 37(6):581-8. PubMed ID: 11105947
[TBL] [Abstract][Full Text] [Related]
40. Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alphaIIb or beta3 allows the expression of a fully functional integrin alphaIIb(beta3): effect of beta3GFP on alphaIIb(beta3) ligand binding.
Plançon S; Morel-Kopp MC; Schaffner-Reckinger E; Chen P; Kieffer N
Biochem J; 2001 Jul; 357(Pt 2):529-36. PubMed ID: 11439104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
